Bulletin
Investor Alert

HilleVax Inc.

NAS: HLVX

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Oct 4, 2022, 12:00 a.m.

/zigman2/quotes/234952647/composite

$

18.98

Change

+0.65 +3.55%

Volume

Volume 93,870

Quotes are delayed by 20 min

/zigman2/quotes/234952647/composite

Previous close

$ 18.33

$ 18.98

Change

+0.65 +3.55%

Day low

Day high

$17.31

$20.10

Open

52 week low

52 week high

$7.90

$24.42

Open

Susan Silbermann

Susan Silbermann is on the board of LianBio and HilleVax, Inc. In her past career she occupied the position of SVP-Worldwide Commercial Development at Pfizer Inc.

Ms. Silbermann received an undergraduate degree from Tufts University, an MBA from The Leonard N Stern School of Business and a graduate degree from New York University.

Transactions

Date Shares Transaction Value

Officers and Executives

Dr. Robert M. Hershberg
Chairman, President & Chief Executive Officer
Dr. Aditya Kohli
Chief Operating Officer & Director
Mr. David A. Socks
Chief Financial & Business Officer
Dr. Astrid Borkowski
Chief Medical Officer
Mr. Paul S. Bavier
Secretary & Chief Administrative Officer
Dr. Gary Dubin
Director
Ms. Kaia Agarwal
Senior Vice President-Regulatory Affairs
Dr. Shelley Chu
Independent Director
Dr. Julie Louise Gerberding
Independent Director
Mr. Patrick J. Heron
Independent Director
Ms. Jeryl Lynn Hilleman
Independent Director
Dr. Jaime Sepulveda
Independent Director
Ms. Susan Silbermann
Independent Director
Link to MarketWatch's Slice.